Literature DB >> 36147753

Central Variant Posterior Reversible Encephalopathy Syndrome in a Pregnant Woman With Eclampsia: A Case Report.

Kevin John John1, Deep P Pillai2, Rhea Anne Roy2, Philip Mathew1, Kuruvilla P Chacko3, John K John2.   

Abstract

Posterior Reversible Encephalopathy Syndrome (PRES) is a clinico-radiological diagnosis characterized by acute or subacute neurological symptoms. A 27-year-old woman at 35 weeks of pregnancy, who presented with generalized tonic-clonic seizures had persistently low Glasgow Coma Scale (GCS) score after delivery of the baby. Magnetic Resonance Imaging (MRI) of the brain showed T-2 Fluid Attenuated Inversion Recovery (FLAIR) hyperintensities in the brainstem, bilateral medial cerebellar hemispheres, bilateral medial temporal lobes, bilateral thalami, lentiform and caudate nuclei, and bilateral fronto-parieto-occipital lobes. There was diffusion restriction in bilateral caudate nuclei, left thalamus and right frontal lobe, and microhemorrhages in the left thalamus. These findings were suggestive of central variant PRES. She improved with strict blood pressure control and anti-edema measures. A repeat MRI brain on day 10 showed significant improvement, and she had no residual neurological deficits. The central variant of PRES is a rare entity that has to be considered in a patient presenting with neurological deficits in the setting of uncontrolled blood pressure, eclampsia, immunomodulatory medication use, or renal failure. While most patients with PRES fully recover with timely therapy targeted at reversing the primary cause, some may have residual neurological deficits or rarely, die.
© The Author(s) 2022.

Entities:  

Keywords:  Eclampsia; Posterior Reversible Encephalopathy Syndrome; Reversible Posterior Leukoencephalopathy Syndrome

Year:  2022        PMID: 36147753      PMCID: PMC9485688          DOI: 10.1177/19418744221110360

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  18 in total

Review 1.  Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches.

Authors:  Guido Granata; Antonio Greco; Giannicola Iannella; Massimo Granata; Alessandra Manno; Ersilia Savastano; Giuseppe Magliulo
Journal:  Autoimmun Rev       Date:  2015-05-18       Impact factor: 9.754

2.  Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging.

Authors:  A M McKinney; B Sarikaya; C Gustafson; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

Review 3.  Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment.

Authors:  R C S Seet; A A Rabinstein
Journal:  QJM       Date:  2011-08-24

4.  Asymmetric posterior reversible encephalopathy syndrome complicating hemodynamic augmentation for subarachnoid hemorrhage-associated cerebral vasospasm.

Authors:  Barbara Voetsch; Nicholas Tarlov; Thanh N Nguyen; Christina DeFusco; Glenn D Barest; Alexander Norbash; Deborah M Green; Joseph D Burns
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 5.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

6.  Posterior reversible encephalopathy syndrome associated with hemodynamic augmentation in aneurysmal subarachnoid hemorrhage.

Authors:  Elias A Giraldo; Jennifer E Fugate; Alejandro A Rabinstein; Giuseppe Lanzino; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

Review 7.  Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.

Authors:  Camille Tlemsani; Olivier Mir; Pascaline Boudou-Rouquette; Olivier Huillard; Karin Maley; Stanislas Ropert; Romain Coriat; François Goldwasser
Journal:  Target Oncol       Date:  2011-11-17       Impact factor: 4.493

8.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

9.  Central-variant posterior reversible encephalopathy syndrome: brainstem or basal ganglia involvement lacking cortical or subcortical cerebral edema.

Authors:  Alexander M McKinney; Bharathi D Jagadeesan; Charles L Truwit
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

10.  Determinants of recovery from severe posterior reversible encephalopathy syndrome.

Authors:  Stephane Legriel; Olivier Schraub; Elie Azoulay; Philippe Hantson; Eric Magalhaes; Isaline Coquet; Cedric Bretonniere; Olivier Gilhodes; Nadia Anguel; Bruno Megarbane; Laurent Benayoun; David Schnell; Gaetan Plantefeve; Julien Charpentier; Laurent Argaud; Bruno Mourvillier; Arnaud Galbois; Ludivine Chalumeau-Lemoine; Michel Rivoal; François Durand; Arnaud Geffroy; Marc Simon; Annabelle Stoclin; Jean-Louis Pallot; Charlotte Arbelot; Martine Nyunga; Olivier Lesieur; Gilles Troché; Fabrice Bruneel; Yves-Sébastien Cordoliani; Jean-Pierre Bedos; Fernando Pico
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.